Drugs / Euvichol
last change Jun 2018 re-read 9 days ago

Euvichol

Vaccine

Developed for
cholera
Investigated by
EuBiologics Co.,Ltd · Instituto Universitario IVI

Trials 2

201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT01707537 Sep 2012 → Feb 2013 — EuBiologics Co.,Ltd Completed No outcome recorded
Phase 31 trial
Phase 3 NCT02164110 May → Sep 2014 — EuBiologics Co.,Ltd Completed No outcome recorded
Comparator or background therapy1 trial
Phase 3 NCT02502331 Comparator Mar → Jun 2016 cholera International Vaccine Institute Unknown No outcome recorded

News releases announcing trial results or a regulatory action · 2

DateIssuerRelease
2016-01-19 EuBiologics Co.,Ltd Regulatory Research Roundup: Vaccines for cholera and river blindness and an online platform for pooled procurement eubiologics.com ↗
Last week, an oral cholera vaccine received World Health Organization (WHO) prequalification, a process of regulatory review which paves the way for procurement by United Nations agencies and international organizations.
2016-01-13 EuBiologics Co.,Ltd Regulatory New affordable oral cholera vaccine receives prequalification by the World Health Organization eubiologics.com ↗
Euvichol®, an inactivated oral cholera vaccine (OCV), recently received prequalification from the World Health Organization (WHO).

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Euvichol “The 600L Euvichol® is safe and immunogenic in adults and children.” PMID 29895500 ↗ Jun 2018
3

NCT01707537 ↗

NCT02502331 ↗

NCT02164110 ↗

Modality Vaccine “Euvichol(Oral cholera vaccine)” NCT01707537 ↗
Route Oral “To Determine the Safety and Immunogenicity of an Oral(Whole Cell) Euvichol Cholera Vaccine” NCT01707537 ↗